Facilitated By

San Antonio Medical Foundation

INCREASING THE POTENCY OF THE VIRAL ANTI-CANCER AGENT REOLYSIN BY ADMINISTERING IT WITH VELCADE (BORTEZOMIB).

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Nawrocki,Steffan T
Funded by
WILLIAM & ELLA OWENS MED RSCH FOUNDATION
Research Start Date
Status
Inactive
Clinical Care
Cancer